Folic Acid Dosing with Methotrexate for Rheumatoid Arthritis

Standard Dosing Recommendation

The minimum effective dose is 5 mg folic acid weekly, which significantly reduces gastrointestinal side effects and hepatotoxicity without compromising methotrexate efficacy, as supported by the American College of Rheumatology guidelines 1, 2, 5
Folic acid supplementation reduces both GI and liver toxicity (OR 0.17 for hepatotoxicity) in a meta-analysis of 788 RA patients 1
The American College of Rheumatology guidelines recommend a minimum of 5 mg folic acid weekly for patients taking methotrexate for rheumatoid arthritis 3, 4

Daily dosing of 1 mg folic acid (7 mg/week total) provides significant hepatoprotection regardless of methotrexate dose, as evidenced by studies published in the Annals of the Rheumatic Diseases 1, 6
Higher doses (10-30 mg/week) can be used if tolerability issues arise, although evidence shows no additional benefit over standard dosing, according to the American College of Rheumatology guidelines 3

For lower methotrexate doses (<10 mg/week), higher folic acid doses (7-35 mg/week) show significant GI protection (OR 0.21) 1, 5
Folinic acid ≤5 mg/week reduces toxicity, but higher folinic acid doses (>5 mg/week) paradoxically increase joint tenderness and swelling, making folic acid the preferred supplement, as reported in the Annals of the Rheumatic Diseases 1, 5, 6

Consider increasing folic acid supplementation above 5 mg/week in patients with persistent gastrointestinal symptoms despite adequate methotrexate dosing, as recommended by the American College of Rheumatology guidelines 3, 4
Patients on higher methotrexate doses (20-30 mg/week) may benefit from proportionally higher folate supplementation, according to studies published in the Annals of the Rheumatic Diseases 1, 5

Do not withhold folic acid, as this concern has been definitively disproven, and folic acid does not reduce methotrexate efficacy, as reported in the Annals of the Rheumatic Diseases 1
Do not use folinic acid at doses >5 mg/week, as this may reduce methotrexate effectiveness, according to the American College of Rheumatology guidelines 1, 5
Do not prescribe less than 5 mg weekly, as lower doses have insufficient evidence for toxicity reduction, as reported in the Annals of the Rheumatic Diseases 1, 2